Jiuqiang Biotech: Announcement of Resolutions of the First Extraordinary Shareholders Meeting in 2026

Securities code: 300406 Securities abbreviation: Jiuqiang Biotech Announcement number: 2026-044 Bond code: 123150 Bond abbreviation: Jiuqiang Convertible Bonds

Beijing Jiuqiang Biotechnology Co., Ltd.

Announcement of Resolutions of the First Extraordinary Shareholders Meeting in 2026

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or major omissions.

Special tips:

1. No resolution was vetoed at this shareholders’ meeting;

2. This shareholders’ meeting does not involve changes to the resolutions passed by previous shareholders’ meetings.

1. Meeting convening and attendance

1. Meeting status

(1) Meeting time:

On-site meeting time: 14:00 on April 27, 2026;

Online voting time: The specific time for online voting through the Shenzhen Stock Exchange system is 9:15-9:25, 9:30-11:30, 13:00-15:00 on April 27, 2026; the specific time for voting through the Shenzhen Stock Exchange Internet voting system is any time from 9:15 to 15:00 on April 27, 2026.

(2) On-site meeting location: Company Conference Room (Fifth Floor, Kuangyi Building, No. 15 Huayuan East Road, Haidian District, Beijing)

(3) Meeting method: combination of on-site voting and online voting.

(4) Meeting convener: Board of Directors of Beijing Jiuqiang Biotechnology Co., Ltd.

(5) Meeting host: Mr. Zou Zuojun, Chairman of the Board

The convening and holding procedures of the meeting comply with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association.

2. Meeting attendance

(1) Overall attendance of shareholders:

There were 184 shareholders voting on site and online, representing 220,017,818 shares, accounting for 37.7542% of the company’s total voting shares.

Among them: 8 shareholders passed on-site voting, representing 214,940,698 shares, accounting for 36.8829% of the company’s total voting shares.

There were 176 shareholders voting online, representing 5,077,120 shares, accounting for 0.8712% of the company’s total voting shares.

(2) Overall attendance of small and medium shareholders:

There were 176 small and medium-sized shareholders voting on site and online, representing 5,077,120 shares, accounting for 0.8712% of the company’s total voting shares.

Among them: 0 small and medium-sized shareholders passed on-site voting, representing 0 shares, accounting for 0.0000% of the company’s total voting shares.

There were 176 small and medium-sized shareholders voting online, representing 5,077,120 shares, accounting for 0.8712% of the company’s total voting shares.

3. Attendance or attendance at the shareholders’ meeting by the company’s directors, senior managers and lawyers

The company's directors, senior managers, and witness lawyers hired by the company attended or attended the shareholders' meeting on site or via online video.

2. Proposal review and voting status

This shareholders’ meeting adopted a combination of on-site voting and online voting to vote, and the following proposals were reviewed and approved:

1. Reviewed and passed a special resolution on the "Proposal on the Board of Directors' Proposal to Revise Down the Conversion Price of the "Nine Top Convertible Bonds""

Total voting results: 216,377,728 shares were approved, accounting for 98.3455% of the total number of shares with valid voting rights present at this shareholders’ meeting; 3,567,290 shares were opposed, accounting for 1.6214% of the total number of shares with valid voting rights present at this shareholders’ meeting; 72,800 shares abstained (of which 0 abstentions were defaulted due to failure to vote) shares), accounting for 0.0331% of the total number of shares with valid voting rights present at this shareholders’ meeting.

The total voting results of small and medium-sized shareholders: 1,437,030 shares were approved, accounting for 28.3040% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 3,567,290 shares were opposed, accounting for 70.2621% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 72,800 shares were abstained (of which, 0 shares were abstained by default due to failure to vote) shares), accounting for 1.4339% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting.

Voting results: passed by more than two-thirds of the valid voting rights held by shareholders (including shareholders’ proxies) present at the shareholders’ meeting.

3. Legal opinions issued by lawyers

1. Name of the law firm witnessing this shareholders’ meeting: Beijing Lianhui Law Firm

2. Witnessing lawyers: Xie Yingni, Liu Zeng

3. Concluding observations: The company’s convening and convening procedures, qualifications of attendees, convenor qualifications, voting procedures, and voting results are all in compliance with the Company Law of the People’s Republic of China, the Rules of Shareholders’ Meetings of Listed Companies and other laws, administrative regulations, rules and other normative documents, as well as the relevant provisions of the Articles of Association. The voting procedures and results of this shareholders’ meeting are legal and valid.

4. Documents for reference

1. Resolution of the first extraordinary shareholders’ meeting in 2026;

2. "Legal Opinion on the First Extraordinary Shareholders Meeting of Beijing Jiuqiang Biotechnology Co., Ltd. in 2026" issued by Beijing Lianhui Law Firm.

Announcement is hereby made.

Board of Directors of Beijing Jiuqiang Biotechnology Co., Ltd.

April 27, 2026